Is this you? Create Your Porfile
Avatar

Daniel J. Cua

Government of the United States of America

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Daniel J. Cua is active.

Explore More

Publication

Featured researches published by Daniel J. Cua.

Archive | 2006

Use of il-23 and il-17 antagonists to treat autoimmune ocular inflammatory disease

Daniel J. Cua; Robert A. Kastelein; Van T. Tsai; Rachel Caspi; Phyllis Silver; Dror Luger

Archive | 2004

Uses of il-23 related reagents

Daniel J. Cua; Yi Chen; Robert A. Kastelein; Claire L. Langrish; Donna M. Rennick; Jonathon Sedgwick

Archive | 2013

Absence of IL-12 Resistance to Acute Toxoplasmosis in the IL-23 Provides a Limited Mechanism of

Christopher A. Hunter; Donna M. Rennick; Daniel J. Cua; A. Lieberman; Fabíola Cardillo

Archive | 2008

Kombinationstherapie zur Behandlung von Immunerkrankungen

Edward P. Bowman; Daniel J. Cua; Robert A. Kastelein; Kathy Lynn Miller; Melanie A. Kleinschek; Kristian Sass Bak-Jensen; Katia Boniface; Brent S. McKenzie; Waal Malefyt Rene De

Archive | 2008

Polythérapie pour le traitement de maladies immunes

Edward P. Bowman; Daniel J. Cua; Robert A. Kastelein; Kathy Lynn Miller; Melanie A. Kleinschek; Kristian Sass Bak-Jensen; Katia Boniface; Brent S. McKenzie; Waal Malefyt Rene De

Archive | 2006

Utilisation des antagonistes IL-23 et IL-17 pour traiter la maladie inflammatoire oculaire auto-immune

Daniel J. Cua; Robert A. Kastelein; Van T. Tsai; Rachel Caspi; Phyllis B. Silver; Dror Luger

Archive | 2006

Verwendung von il-23 und il-17-antagonisten zur behandlung von autoimmuner entzündlicher augenerkrankung Use of IL-23 and IL-17 antagonists for the treatment of autoimmune inflammatory eye disease

Daniel J. Cua; Robert A. Kastelein; Van T. Tsai; Rachel Caspi; Phyllis B. Silver; Dror Luger

Archive | 2006

Verwendung von il-23 und il-17-antagonisten zur behandlung von autoimmuner entzündlicher augenerkrankung

Daniel J. Cua; Robert A. Kastelein; Van T. Tsai; Rachel Caspi; Phyllis B. Silver; Dror Luger

Archive | 2006

Verwendung von IL-23- und IL-17-Antagonisten zur Behandlung von Augenentzündungsautoimmunerkrankungen

Daniel J. Cua; Robert A. Kastelein; Van T. Tsai; Rachel Caspi; Phyllis B. Silver; Dror Luger

Archive | 2006

Uso de antagonistas de il-23 e il-17 para tratar la enfermedad inflamatoria ocular autoinmunologica.

Rachel Caspi; Daniel J. Cua; Robert A. Kastelein; Dror Luger; Phyllis B. Silver; Van T. Tsai

Explore More

Collaboration

Dive into the Daniel J. Cua's collaboration.

Top Co-Authors
Avatar

Robert A. Kastelein

University of California

View shared research outputs
Top Co-Authors
Avatar

Dror Luger

National Institutes of Health

View shared research outputs
Top Co-Authors
Avatar

Phyllis B. Silver

National Institutes of Health

View shared research outputs
Top Co-Authors
Avatar

Donna M. Rennick

University of California

View shared research outputs
Top Co-Authors
Avatar

Claire L. Langrish

Schering-Plough

View shared research outputs
Top Co-Authors
Avatar

Edward P. Bowman

Schering-Plough

View shared research outputs
Top Co-Authors
Avatar

Jonathon Sedgwick

Schering-Plough

View shared research outputs
Top Co-Authors
Avatar

Kathy Lynn Miller

Schering-Plough

View shared research outputs
Top Co-Authors
Avatar

Katia Boniface

Merck

View shared research outputs
Top Co-Authors
Avatar

Kristian Sass Bak-Jensen

Schering-Plough

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge